NCT04799379View on ClinicalTrials.gov

Microporous Polysaccharide Hemospheres (MPH) Improving Outcome After Rectal Surgery

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions
Postoperative Sepsis
Interventions
DRUG

microporous polysaccharide hemospheres (MPH) agent in rectal surgery

Use of microporous polysaccharide hemospheres (MPH) agent in patients after rectal surgery to avoid pelvic collections and the use of any drain

Trial Locations (5)

Unknown

Hospital General Universitario de Elche, Elche

Hospital de la RIBERA, Alzira

Hospital Jimenz diaz, Madrid

Hospital Universitario Infanta Leonor, Madrid

Hospital Clínico Universitario Lozano Blesa, Zaragoza

All Listed Sponsors
collaborator

Universidad de Zaragoza

OTHER

collaborator

Aragon Health Science Institute

OTHER_GOV

lead

Grupo Español de Rehabilitación Multimodal

OTHER

NCT04799379 - Microporous Polysaccharide Hemospheres (MPH) Improving Outcome After Rectal Surgery | Biotech Hunter | Biotech Hunter